While there was no evidence of differential SH3BP4 expression in metastatic compared to primary tumors (p=0.20), upregulation of MELK was observed in metastatic tissues (p=2.85×10-33), providing further support that MELK may stimulate tumor progression. Here, SH3BP4 is linked to neoplasm.